AA
NVS icon

Addison Advisors’s Novartis NVS Stock Holding History

Addison Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.6K Sell
597
-2,535
-81% -$380K 0.04% 186
2026
Q1 		$478K Sell
3,132
-21
-0.7% -$3.22K 0.11% 134
2025
Q4 		$435K Buy
3,153
+125
+4% +$16.4K 0.1% 140
2025
Q3 		$388K Buy
3,028
+56
+2% +$6.83K 0.09% 147
2025
Q2 		$360K Buy
2,972
+236
+9% +$26.6K 0.09% 152
2025
Q1 		$305K Sell
2,736
-52
-2% -$5.54K 0.08% 154
2024
Q4 		$271K Buy
2,788
+5
+0.2% +$533 0.08% 165
2024
Q3 		$320K Buy
2,783
+121
+5% +$13.7K 0.09% 155
2024
Q2 		$283K Buy
2,662
+351
+15% +$35.2K 0.09% 154
2024
Q1 		$224K Buy
2,311
+22
+1% +$2.26K 0.08% 171
2023
Q4 		$231K Buy
2,289
+209
+10% +$20.2K 0.09% 157
2023
Q3 		$212K Buy
2,080
+242
+13% +$24.6K 0.1% 145
2023
Q2 		$185K Buy
1,838
+181
+11% +$18.1K 0.09% 161
2023
Q1 		$152K Sell
1,657
-63
-4% -$5.5K 0.09% 165
2022
Q4 		$156K Buy
1,720
+323
+23% +$27.2K 0.09% 148
2022
Q3 		$106K Buy
1,397
+112
+9% +$9.28K 0.07% 184
2022
Q2 		$109K Sell
1,285
-130
-9% -$11.4K 0.07% 180
2022
Q1 		$124K Buy
1,415
+884
+166% +$76.5K 0.07% 191
2021
Q4 		$46K Buy
531
+92
+21% +$7.64K 0.03% 254
2021
Q3 		$36K Buy
439
+14
+3% +$1.26K 0.03% 209
2021
Q2 		$39K Buy
+425
New +$37.8K 0.03% 202
2020
Q4 		$40K Buy
+425
New +$37.1K 0.04% 196

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Addison Advisors's NVS Position: Q2 2026 in Review

Addison Advisors reduced its Novartis (NVS) stake by 81% in Q2 2026, selling an estimated $380K and leaving 597 shares worth $93.6K. The position accounts for 0.04% of the portfolio, ranked #186.

Addison Advisors first reported a position in NVS in Q4 2020 and has held it in 22 quarters since. The position peaked at $478K in Q1 2026. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Addison Advisors held 597 shares of Novartis worth $93.6K as of Q2 2026.
  • Addison Advisors sold 2,535 Novartis shares in Q2 2026, an estimated $380K.
  • Novartis made up 0.04% of Addison Advisors's portfolio in Q2 2026, its #186 holding.
  • Addison Advisors first reported a position in Novartis in Q4 2020 and has held it in 22 quarters since.
  • Addison Advisors's Novartis position peaked at $478K in Q1 2026.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.